CI
SAGE

Cavalier Investments’s Sage Therapeutics SAGE Stock Holding History

Cavalier Investments’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,837
Closed -$85.5K – 84
2024
Q3 		$85.5K Buy
11,837
+690
+6% +$6.32K 0.03% 84
2024
Q2 		$121K Buy
11,147
+310
+3% +$3.97K 0.04% 79
2024
Q1 		$203K Buy
10,837
+569
+6% +$13.1K 0.07% 81
2023
Q4 		$223K Buy
10,268
+240
+2% +$4.76K 0.08% 90
2023
Q3 		$206K Buy
10,028
+349
+4% +$10.1K 0.08% 93
2023
Q2 		$455K Buy
+9,679
New +$482K 0.17% 92

Other funds holding SAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return